Mostrando 3 resultados de: 3
Role of endocrine-disrupting chemicals in the pathogenesis of non-alcoholic fatty liver disease: A comprehensive review
ReviewAbstract: Non-alcoholic fatty liver disease (NAFLD) is considered the most common liver disorder, affecting arPalabras claves:Endocrine-disrupting chemicals, Environmental pollutants, Exposure, Liver disorder, Non-alcoholic fatty liver diseaseAutores:Cano G., Cano R.A., Dávila L.C.A., Diaz M.P., Gomez Y., González M.C., Manzano A., Ortega A., Parra H., Pérez J.L., Rojas-Quintero J., Valero-Cedeño N.J., Valmore Bermúdez, Veliz T.Fuentes:scopusSpecialized Proresolving Lipid Mediators: A Potential Therapeutic Target for Atherosclerosis
ReviewAbstract: Cardiovascular disease (CVD) is a global public health issue due to its high morbidity, mortality, aPalabras claves:atherosclerosis, inflammation, Intimal hyperplasia, Reperfusion injury, resolution, Specialized proresolving mediatorsAutores:Añez-Ramos R., Castro A., Dávila L.C.A., de Sanctis J.B., Diaz A., Durán-Agüero S., Galbán N., González M.C., Nava M., Parra H., Pírela D., Rojas-Gómez D.M., Salazar-Vílchez J., Valmore Bermúdez, Villasmil N.Fuentes:scopusThe yap/taz signaling pathway in the tumor microenvironment and carcinogenesis: Current knowledge and therapeutic promises
ReviewAbstract: The yes-associated protein (YAP) and the transcriptional coactivator with PDZ-binding motif (TAZ) arPalabras claves:Carcinogenesis, cell proliferation, Chemoresistance, Drug resistance, Hippo signaling pathway, immunotherapy, Neoplastic stem cells, TEAD, tumor microenvironment, YAP/TAZAutores:de Sanctis J.B., Diaz M.P., Navarro C., Ortega A., Parra H., Rojas M., Salazar-Vílchez J., Torres W., Valmore Bermúdez, Vera I.Fuentes:scopus